Ann Thorac Surg 2006;81:1218-1219
© 2006 The Society of Thoracic Surgeons
Original article: General thoracic
Invited commentary
Henning Gaissert, MD
Thoracic Surgical Unit, Massachusetts General Hospital, 55 Fruit St, Blake 1570, Boston, MA 02114
(Email: hgaissert@partners.org).
| The first 20% of the full text of this article appears below. |
 |
Introduction
|
|---|
This article [1] describes chest wall lymphoma as a separate entity in 7 patients and shows long-term survival after surgical resection with postoperative chemotherapy in 3 of the 7. The fact that surgeons are the authors of this article should be no surprise. An account of site-specific characteristics in non-Hodgkin's lymphoma (NHL) seems less important when treatment is based mainly on cell type. What do we learn? A palpable mass was present in all patients, associated with pain or rib destruction in 3 patients each. Histology is described as diffuse B-cell in 5 patients and "malignant" in 2. Bone marrow biopsy was negative in all; 3 patients had disease in other sites.
Patients arrived . . . [Full Text of this Article]
Copyright © 2006 by The Society of Thoracic Surgeons.